Isothermal Nucleic Acid Amplification Technology (INAAT) Market, by Product Type (Instruments and Reagents), by Technology (Helicase Dependent Amplification (HAD), Nicking Enzyme Amplification Reaction (NEAR), Nucleic Acid Sequence Based Amplification (NA

Isothermal Nucleic Acid Amplification Technology (INAAT) Market, by Product Type (Instruments and Reagents), by Technology (Helicase Dependent Amplification (HAD), Nicking Enzyme Amplification Reaction (NEAR), Nucleic Acid Sequence Based Amplification (NASBNA), Transcription medicated amplification (TMA), Single primer Isothermal Amplification (SPIA), and Loop-mediated Isothermal Amplification (LAMP)), by Application (Blood Screening, Oncology, Research and Development activities, and Others), by End User (Academic and Research Institutes, Diagnostic Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast 2018 - 2026

Isothermal nucleic acid technologies are used in recombinant DNA and molecular biology techniques. These techniques are used in detection and analysis of a small quantity of nucleic acids. Polymerases chain reaction is based on isothermal nucleic acid amplification technology. The polymerase chain reaction (PCR) is most widely used method for DNA amplification. Polymerase chain reaction (PCR) is used for the detection and identification of infectious diseases, genetic disorders, and for research purposes. PCR consists a thermocycling machine, which facilitates separation and amplification of DNA strands.

Market Dynamics

Increasing approvals from healthcare regulatory authorities for innovative technologies is expected to drive the global isothermal nucleic acid amplification technology (INAAT) market growth. For instance, in October 2018, Abbott laboratories received the U.S. Food and Drug Administration (FDA) for its next-generation Influenza A & B2 and Strep A2 molecular assays. These assays are used for the molecular detection and differentiation of influenza A and B virus. Next-generation Influenza A & B2 and Strep A2 molecular assays are currently available on ID NOW platform, which is a rapid isothermal system. It is used for the detection of infectious diseases such as influenza.

Furthermore, rising product launches by key players is expected to boost the global isothermal nucleic acid amplification technology (INAAT) market growth. For instance, in July 2017, TwistDx Inc. launched TwistAmp, a recombinase polymerase amplification (RPA) kit. It is used for DNA/RNA amplification. TwistAmp is an isothermal alternative to polymerase chain reaction PCR.

Key features of the study:

• This report provides in-depth analysis of the global isothermal nucleic acid amplification technology (INAAT) market size (US$ Mn), and compound annual growth rate (CAGR %) for the forecast period (2018–2026), considering 2017, as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global isothermal nucleic acid amplification technology (INAAT) market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include, Alere Inc., Becton, Dickinson & Company, BioHelix Corporation, BioMerieux Biotechnology Company, Hologic Gene-Probe, QIAGEN Company, Thermo Fisher Scientific, Inc., Lucigen Corporation, Quidel Corporation, and NuGEN
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The global isothermal nucleic acid amplification technology (INAAT) market report caters to various stakeholders in this industry including investors, product manufacturers, distributors, and suppliers for isothermal nucleic acid amplification technology (INAAT) market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

• Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Product Type:
• Instruments
• Reagents
• Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Application:
• Blood Screening
• Oncology
• Research and Development Activities
• Others
• Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Technology:
• Helicase Dependent Amplification (HAD)
• Nicking Enzyme Amplification Reaction (NEAR)
• Nucleic Acid Sequence Based Amplification (NASBA)
• Transcription Medicated Amplification (TMA)
• Single Primer Isothermal Amplification (SPIA)
• Loop-mediated Isothermal Amplification (LAMP)
• Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By End User Type:
• Academic and Research Institutes
• Diagnostic Laboratories
• Others
• Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market , By Region:
• North America
• By Country:
• U.S.
• Canada
• By Product Type:
• Instruments
• Reagents
• By Technology:
• Helicase Dependent Amplification (HAD)
• Nicking Enzyme Amplification Reaction (NEAR)
• Nucleic Acid Sequence Based Amplification (NASBA)
• Transcription Medicated Amplification (TMA)
• Single Primer Isothermal Amplification (SPIA)
• Loop-mediated Isothermal Amplification (LAMP)
• By Application:
• Blood Screening
• Oncology
• Research and Development Activities
• Others
• By End User Type:
• Academic and Research Institutes
• Diagnostic Laboratories
• Others
• Europe
• By Country:
• U.K.
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe
• By Product Type:
• Instruments
• Reagents
• By Technology:
• Helicase Dependent Amplification (HAD)
• Nicking Enzyme Amplification Reaction (NEAR)
• Nucleic Acid Sequence Based Amplification (NASBA)
• Transcription Medicated Amplification (TMA)
• Single Primer Isothermal Amplification (SPIA)
• Loop-mediated Isothermal Amplification (LAMP)
• By Application:
• Blood Screening
• Oncology
• Research and Development Activities
• Others
• By End User Type:
• Academic and Research Institutes
• Diagnostic Laboratories
• Others
• Asia Pacific
• By Country:
• Australia
• India
• China
• Japan
• ASEAN
• South Korea
• Rest of Asia Pacific
• By Product Type:
• Instruments
• Reagents
• By Technology
• Helicase Dependent Amplification (HAD)
• Nicking Enzyme Amplification Reaction (NEAR)
• Nucleic Acid Sequence Based Amplification (NASBA)
• Transcription Medicated Amplification (TMA)
• Single Primer Isothermal Amplification (SPIA)
• Loop-mediated Isothermal Amplification (LAMP)
• By Application:
• Blood Screening
• Oncology
• Research and Development Activities
• Others
• By End User Type:
• Academic and Research Institutes
• Diagnostic Laboratories
• Others
• Latin America
• By Country:
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• By Product Type:
• Instruments
• Reagents
• By Technology:
• Helicase Dependent Amplification (HAD)
• Nicking Enzyme Amplification Reaction (NEAR)
• Nucleic Acid Sequence Based Amplification (NASBA)
• Transcription Medicated Amplification (TMA)
• Single Primer Isothermal Amplification (SPIA)
• Loop-mediated Isothermal Amplification (LAMP)
• By Application:
• Blood Screening
• Oncology
• Research and Development Activities
• Others
• By End User Type:
• Academic and Research Institutes
• Diagnostic Laboratories
• Others
• Middle East
• By Country:
• GCC Countries
• Israel
• Rest of Middle East
• By Product Type:
• Instruments
• Reagents
• By Technology:
• Helicase Dependent Amplification (HAD)
• Nicking Enzyme Amplification Reaction (NEAR)
• Nucleic Acid Sequence Based Amplification (NASBA)
• Transcription Medicated Amplification (TMA)
• Single Primer Isothermal Amplification (SPIA)
• Loop-mediated Isothermal Amplification (LAMP)
• By Application:
• Blood Screening
• Oncology
• Research and Development Activities
• Others
• By End User Type:
• Academic and Research Institutes
• Diagnostic Laboratories
• Others
• Africa
• By Country/Region:
• South Africa
• Central Africa
• North Africa
• By Product Type:
• Instruments
• Reagents
• By Technology:
• Helicase Dependent Amplification (HAD)
• Nicking Enzyme Amplification Reaction (NEAR)
• Nucleic Acid Sequence Based Amplification (NASBA)
• Transcription Medicated Amplification (TMA)
• Single Primer Isothermal Amplification (SPIA)
• Loop-mediated Isothermal Amplification (LAMP)
• By Application:
• Blood Screening
• Oncology
• Research and Development Activities
• Others
• By End User Type:
• Academic and Research Institutes
• Diagnostic Laboratories
• Others
• Company Profiles
• Alere Inc.,*
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Highlights
• Strategies
• Becton, Dickinson & Company
• BioHelix Corporation
• BioMerieux Biotechnology Company
• Hologic Gene-Probe
• QIAGEN Company
• Thermo Fisher Scientific, Inc.
• Lucigen Corporation
• Quidel Corporation
• NuGEN

“*” marked represents similar segmentation in other categories in the respective section.